Tocqueville Asset Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Tocqueville Asset Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-19,175	Closed	-$1.02M	–	913
2016 Q1	$1.02M	Buy	19,175 +50	+0.3%	+$3.69K	0.01%	500
2015 Q4	$2.16M	Buy	19,125 +3,100	+19%	+$342K	0.03%	410
2015 Q3	$1.89M	Buy	+16,025	New	+$2.09M	0.03%	447

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Tocqueville Asset Management's ANAC Position: Q2 2016 in Review

Tocqueville Asset Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 19,175 shares — an estimated $1.02M sold.

Tocqueville Asset Management first reported a position in ANAC in Q3 2015 and held it in 3 quarters. The position peaked at $2.16M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Tocqueville Asset Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Tocqueville Asset Management sold 19,175 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $1.02M.
Tocqueville Asset Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 3 quarters.
Tocqueville Asset Management's ANACOR PHARMACEUTICALS INC COM position peaked at $2.16M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Tocqueville Asset Management's 13F filing for Q2 2016, filed 29 Jul 2016.